Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Barclays ups CVS Health to Buy on positive margin outlook
CVS Health upgraded at Barclays on Medicare prospects
Barclays upgraded CVS Health (NYSE:CVS) to Overweight from Equal Weight on Thursday, citing a compelling path to margin recovery given recent updates regarding the insurance giant's Medicare Advantage business.
Positive Report for CVS Health (CVS) from Barclays
CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The
Barclays ups CVS Health to Buy on positive margin outlook; shares rise
Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares to $82 from $63.
CVS, Cigna and Lina Khan
CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand.
UnitedHealth, CVS, Cigna accuse FTC Chair Khan of 'serious bias' against PBMs
CVS Health (NYSE:CVS), and the Cigna Group (NYSE:CI) are asking that FTC Chair Lina Khan and two other commissioners recuse themselves from a case against pharmacy benefit managers, accusing the trio of "serious bias" based on public statements.
Modern Healthcare
5h
Oak Street Health expansion to continue amid CVS review
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
3d
on MSN
CVS is under pressure and considering a breakup. Here's why that could be risky.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
1d
on MSN
CVS to lay off 632 people tied to RI HQ as board mulls breaking up company
The company announced on Sept. 30 it was laying off nearly 3,000 people nationally as it seeks to cut $2 billion in expenses ...
2d
More than 80 R.I. residents to lose jobs as part of CVS layoffs
More than 600 employees who work out of CVS Health’s Woonsocket headquarters, including 80 state residents, will lose their ...
2d
CVS to cut more than 630 jobs that report to Rhode Island headquarters
Only 153 of the terminated employees work at the Woonsocket headquarters or surrounding facilities while the remaining ...
NJBIZ
18h
Another round of layoffs coming to CVS Health in New Jersey
The Woonsocket, R.I.-based health care giant said it would cut more than 100 positions in January at its corporate office in ...
4d
Does This New Development Make CVS Stock a Buy or a Sell?
Overall, the new announcement pushes CVS toward being a stock worth selling rather than buying. None of the newly announced ...
The Day
1d
CVS Health to lay off 416 employees tied to Aetna's Hartford headquarters
CVS Health told the state of Connecticut on Monday it would be laying off 416 employees linked to the Hartford headquarters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Cigna
Lina Khan
UnitedHealth Group
Federal Trade Commission
Feedback